SEC Form 4 · accession 0001209191-17-065525
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maky Zanganeh
Director
Period of report
Dec 11, 2017
Accepted (ET)
Dec 13, 2017 · 8:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 11, 2017 | P | 3,000 | $22.763 | A | 93,474 | I | Dependent Minor |
| Common StockF2 | Dec 12, 2017 | P | 1,000 | $23.979 | A | 94,474 | I | Dependent Minor |
| Common Stock | holding | — | — | — | 332,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This is the weighted average purchase price of the shares, which ranged from $22.59 to $22.98 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F2This is the weighted average purchase price of the shares, which ranged from $23.92 to $24.03 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.